An Innovatix Publication Series
EDITORIAL STAFF EDITOR IN CHIEF
Gary Feit, MS Vice President, Corporate Communications
CLINICAL EDITOR
Sylvia Thomas, PharmD, MS, BCPS Vice President, Clinical Pharmacy Services
MANAGING EDITOR
Eric Rodriguez Director, Corporate Communications
Table of Contents Issue 1 | 2018
DESIGNER
Jaclyn Alvarado Creative Director, J2 Design NYC, Inc.
COPY EDITOR Tina Harlan
PROOFREADER Laura F. Yandell
CONTRIBUTORS
1 Welcome Letter the Ready: Emergency Preparation and 2 AtResponse for Healthcare Facilities Employee Spending: Four Tips 7 Managing to Improve Your Bottom Line Is Your Pharmacy Safe and 9 Cyberattacks: Do You Have Proper Protections in Place? Policy Win: Home Infusion 12 Landmark Services Billed Under Medicare Innovatix IVIG Calculator: 15 The Q&A with Dr. Liya Davydov Education: Heart Failure: 17 Continuing A Guideline Directed Medical Therapy
Approach to Diagnosis and Treatment
34 Clinical Corner: Shingrix 37 Contract Updates 2 |
Insight
Leigh Davitian, JD Liya Davydov, PharmD, BCPS, BCGP Gary Feit, MS Renee Hofman, MS, RPh Eric Rodriguez Alicia Schindle Shara Siegel, MS Sylvia Thomas, PharmD, MS, BCPS
555 West 57th St., 12th Floor New York, NY 10019 phone 888.258.3273 fax 646.638.2641 innovatix.com Insight magazine is published semiannually by Innovatix and is complimentary for Innovatix members. For membership information, please call 888.258.3273. To submit ideas for editorial consideration, please contact Eric Rodriguez at 212.901.1242 or eric_rodriguez@innovatix.com. This publication is intended to provide general information on issues of interest to the members of Innovatix, LLC (“Innovatix�) and the general public. It does not constitute nor should it be used as a substitute for any business, legal, or regulatory advice. Innovatix hereby disclaims all warranties, express or implied, as to the accuracy of any of the information contained herein, whether such information is up-to-date, or its fitness for any particular use or purpose. Nothing contained in it is intended as a treatment recommendation for any particular patient or group of patients. Treating institutions and/ or physicians must make all clinical decisions regarding the use of pharmaceuticals and other products on a case-by-case basis. You should always refer to federal, state, and local laws, rules, and regulations governing the operation of your organization and should consult your own legal counsel. The opinions expressed by the authors of articles included in this issue do not necessarily reflect those of Innovatix, its affiliates, or its representatives. Furthermore, some of the content contained herein may have been originally prepared by or funded by organizations with financial interests in products or services related to the topics discussed in such article. While every effort was made to ensure the accuracy of information conveyed in this magazine, Innovatix, its affiliates, and its representatives do not accept responsibility and cannot be held liable for any errors that may exist within the publication. Innovatix is not responsible for the contents of any Web pages that are referenced by this communication. Links from this communication to other sites do not constitute an endorsement by Innovatix. These links are for convenience only. It is the responsibility of the user to evaluate the content and usefulness of information obtained from other sites. Innovatix has no control over and is not responsible for the information, practices, or content of these or any other sites. The contents of this publication are protected by copyright and are the property of Innovatix. They may not be reproduced or transmitted in any form without the express written permission of Innovatix.